Chargement en cours...
Recent Advances in Systemic Therapies for Advanced Hepatocellular Carcinoma
PURPOSE OF REVIEW: This paper aims to summarize the data of recently completed and key ongoing clinical trials of systemic agents for advanced hepatocellular carcinoma (aHCC). In particular, the review focuses on ongoing checkpoint inhibitor combination trials and promising studies combining tyrosin...
Enregistré dans:
| Publié dans: | Curr Hepatol Rep |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer US
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7848044/ https://ncbi.nlm.nih.gov/pubmed/33552839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11901-021-00560-2 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|